Georg Widhalm1,2, Jonathan Olson3, Jonathan Weller1, Jaime Bravo3, Seunggu J Han1,4, Joanna Phillips5, Shawn L Hervey-Jumper1, Susan M Chang1, David W Roberts3,6, Mitchel S Berger1. 1. Departments of1Neurological Surgery and. 2. 2Department of Neurosurgery, Medical University of Vienna, Austria. 3. 3Thayer School of Engineering, Dartmouth College, Hanover. 4. 4Department of Neurological Surgery, Oregon Health and Sciences University, Portland, Oregon. 5. 5Pathology, University of California, San Francisco, California. 6. 6Section of Neurosurgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; and.
Abstract
OBJECTIVE: In patients with suspected diffusely infiltrating low-grade gliomas (LGG), the prognosis is dependent especially on extent of resection and precision of tissue sampling. Unfortunately, visible 5-aminolevulinic acid (5-ALA) fluorescence is usually only present in high-grade gliomas (HGGs), and most LGGs cannot be visualized. Recently, spectroscopic probes were introduced allowing in vivo quantitative analysis of intratumoral 5-ALA-induced protoporphyrin IX (PpIX) accumulation. The aim of this study was to intraoperatively investigate the value of visible 5-ALA fluorescence and quantitative PpIX analysis in suspected diffusely infiltrating LGG. METHODS: Patients with radiologically suspected diffusely infiltrating LGG were prospectively recruited, and 5-ALA was preoperatively administered. During resection, visual fluorescence and absolute tissue PpIX concentration (CPpIX) measured by a spectroscopic handheld probe were determined in different intratumoral areas. Subsequently, corresponding tissue samples were safely collected for histopathological analysis. Tumor diagnosis was established according to the World Health Organization 2016 criteria. Additionally, the tumor grade and percentage of tumor cells were investigated in each sample. RESULTS: All together, 69 samples were collected from 22 patients with histopathologically confirmed diffusely infiltrating glioma. Visible fluorescence was detected in focal areas in most HGGs (79%), but in none of the 8 LGGs. The mean CPpIX was significantly higher in fluorescing samples than in nonfluorescing samples (0.693 μg/ml and 0.008 μg/ml, respectively; p < 0.001). A significantly higher mean percentage of tumor cells was found in samples with visible fluorescence compared to samples with no fluorescence (62% and 34%, respectively; p = 0.005), and significant correlation of CPpIX and percentage of tumor cells was found (r = 0.362, p = 0.002). Moreover, high-grade histology was significantly more common in fluorescing samples than in nonfluorescing samples (p = 0.001), whereas no statistically significant difference in mean CPpIX was noted between HGG and LGG samples. Correlation between maximum CPpIX and overall tumor grade was highly significant (p = 0.005). Finally, 14 (40%) of 35 tumor samples with no visible fluorescence and 16 (50%) of 32 LGG samples showed significantly increased CPpIX (cutoff value: 0.005 μg/ml). CONCLUSIONS: Visible 5-ALA fluorescence is able to detect focal intratumoral areas of malignant transformation, and additional quantitative PpIX analysis is especially useful to visualize mainly LGG tissue that usually remains undetected by conventional fluorescence. Thus, both techniques will support the neurosurgeon in achieving maximal safe resection and increased precision of tissue sampling during surgery for suspected LGG.Clinical trial registration no.: NCT01116661 (clinicaltrials.gov).
OBJECTIVE: In patients with suspected diffusely infiltrating low-grade gliomas (LGG), the prognosis is dependent especially on extent of resection and precision of tissue sampling. Unfortunately, visible 5-aminolevulinic acid (5-ALA) fluorescence is usually only present in high-grade gliomas (HGGs), and most LGGs cannot be visualized. Recently, spectroscopic probes were introduced allowing in vivo quantitative analysis of intratumoral 5-ALA-induced protoporphyrin IX (PpIX) accumulation. The aim of this study was to intraoperatively investigate the value of visible 5-ALA fluorescence and quantitative PpIX analysis in suspected diffusely infiltrating LGG. METHODS:Patients with radiologically suspected diffusely infiltrating LGG were prospectively recruited, and 5-ALA was preoperatively administered. During resection, visual fluorescence and absolute tissue PpIX concentration (CPpIX) measured by a spectroscopic handheld probe were determined in different intratumoral areas. Subsequently, corresponding tissue samples were safely collected for histopathological analysis. Tumor diagnosis was established according to the World Health Organization 2016 criteria. Additionally, the tumor grade and percentage of tumor cells were investigated in each sample. RESULTS: All together, 69 samples were collected from 22 patients with histopathologically confirmed diffusely infiltrating glioma. Visible fluorescence was detected in focal areas in most HGGs (79%), but in none of the 8 LGGs. The mean CPpIX was significantly higher in fluorescing samples than in nonfluorescing samples (0.693 μg/ml and 0.008 μg/ml, respectively; p < 0.001). A significantly higher mean percentage of tumor cells was found in samples with visible fluorescence compared to samples with no fluorescence (62% and 34%, respectively; p = 0.005), and significant correlation of CPpIX and percentage of tumor cells was found (r = 0.362, p = 0.002). Moreover, high-grade histology was significantly more common in fluorescing samples than in nonfluorescing samples (p = 0.001), whereas no statistically significant difference in mean CPpIX was noted between HGG and LGG samples. Correlation between maximum CPpIX and overall tumor grade was highly significant (p = 0.005). Finally, 14 (40%) of 35 tumor samples with no visible fluorescence and 16 (50%) of 32 LGG samples showed significantly increased CPpIX (cutoff value: 0.005 μg/ml). CONCLUSIONS: Visible 5-ALA fluorescence is able to detect focal intratumoral areas of malignant transformation, and additional quantitative PpIX analysis is especially useful to visualize mainly LGG tissue that usually remains undetected by conventional fluorescence. Thus, both techniques will support the neurosurgeon in achieving maximal safe resection and increased precision of tissue sampling during surgery for suspected LGG.Clinical trial registration no.: NCT01116661 (clinicaltrials.gov).
Entities:
Keywords:
5-ALA = 5-aminolevulinic acid; CE = contrast enhancement; CPpIX = PpIX concentration; DTI = diffusion tensor imaging; HGG = high-grade glioma; IDH = isocitrate dehydrogenase; LGG = low-grade glioma; MRI = magnetic resonance imaging; NPV = negative predictive value; PPV = positive predictive value; PpIX = protoporphyrin IX; PpIX analysis; ROC = receiver operating characteristic; San Francisco; UCSF = University of California; WHO = World Health Organization; anaplastic foci; oncology; suspected LGG; tumor visualization; visible fluorescence
Authors: Georg Widhalm; Martin Krssak; Georgi Minchev; Adelheid Wöhrer; Tatjana Traub-Weidinger; Thomas Czech; Susanne Asenbaum; Christine Marosi; Engelbert Knosp; Johannes A Hainfellner; Daniela Prayer; Stefan Wolfsberger Journal: J Neurol Neurosurg Psychiatry Date: 2010-10-22 Impact factor: 10.154
Authors: Michael Weller; Martin van den Bent; Jörg C Tonn; Roger Stupp; Matthias Preusser; Elizabeth Cohen-Jonathan-Moyal; Roger Henriksson; Emilie Le Rhun; Carmen Balana; Olivier Chinot; Martin Bendszus; Jaap C Reijneveld; Frederick Dhermain; Pim French; Christine Marosi; Colin Watts; Ingela Oberg; Geoffrey Pilkington; Brigitta G Baumert; Martin J B Taphoorn; Monika Hegi; Manfred Westphal; Guido Reifenberger; Riccardo Soffietti; Wolfgang Wick Journal: Lancet Oncol Date: 2017-05-05 Impact factor: 41.316
Authors: Georg Widhalm; Barbara Kiesel; Adelheid Woehrer; Tatjana Traub-Weidinger; Matthias Preusser; Christine Marosi; Daniela Prayer; Johannes A Hainfellner; Engelbert Knosp; Stefan Wolfsberger Journal: PLoS One Date: 2013-10-18 Impact factor: 3.240
Authors: Mohammed Jaber; Johannes Wölfer; Christian Ewelt; Markus Holling; Martin Hasselblatt; Thomas Niederstadt; Tarek Zoubi; Matthias Weckesser; Walter Stummer Journal: Neurosurgery Date: 2016-03 Impact factor: 4.654
Authors: Mario Mischkulnig; Thomas Roetzer-Pejrimovsky; Daniela Lötsch-Gojo; Nina Kastner; Katharina Bruckner; Romana Prihoda; Alexandra Lang; Mauricio Martinez-Moreno; Julia Furtner; Anna Berghoff; Adelheid Woehrer; Walter Berger; Georg Widhalm; Barbara Kiesel Journal: Front Med (Lausanne) Date: 2022-05-18
Authors: David Reichert; Mikael T Erkkilä; Gerhard Holst; Nancy Hecker-Denschlag; Marco Wilzbach; Christoph Hauger; Wolfgang Drexler; Johanna Gesperger; Barbara Kiesel; Thomas Roetzer; Angelika Unterhuber; Georg Widhalm; Rainer A Leitgeb; Marco Andreana Journal: Biomed Opt Express Date: 2020-02-26 Impact factor: 3.732
Authors: Mikael T Erkkilä; David Reichert; Johanna Gesperger; Barbara Kiesel; Thomas Roetzer; Petra A Mercea; Wolfgang Drexler; Angelika Unterhuber; Rainer A Leitgeb; Adelheid Woehrer; Angelika Rueck; Marco Andreana; Georg Widhalm Journal: Sci Rep Date: 2020-11-24 Impact factor: 4.379
Authors: Mario Mischkulnig; Barbara Kiesel; Daniela Lötsch; Thomas Roetzer; Martin Borkovec; Lisa I Wadiura; Petra A Mercea; Florian J Jaklin; Shawn Hervey-Jumper; Karl Roessler; Mitchel S Berger; Georg Widhalm; Friedrich Erhart Journal: Cancers (Basel) Date: 2020-07-24 Impact factor: 6.639
Authors: Jeffrey I Traylor; Mark N Pernik; Alex C Sternisha; Samuel K McBrayer; Kalil G Abdullah Journal: Cancers (Basel) Date: 2021-02-02 Impact factor: 6.639
Authors: Giuseppe Palmieri; Fabio Cofano; Luca Francesco Salvati; Matteo Monticelli; Pietro Zeppa; Giuseppe Di Perna; Antonio Melcarne; Roberto Altieri; Giuseppe La Rocca; Giovanni Sabatino; Giuseppe Maria Barbagallo; Fulvio Tartara; Francesco Zenga; Diego Garbossa Journal: Technol Cancer Res Treat Date: 2021 Jan-Dec
Authors: Petros D Petridis; Craig I Horenstein; Brianna Pereira; Peter B Wu; Jorge Samanamud; Tamara Marie; Deborah Boyett; Tejaswi D Sudhakar; Sameer A Sheth; Guy M McKhann; Michael B Sisti; Jeffrey N Bruce; Peter Canoll; Jack Grinband Journal: Neuro Oncol Date: 2022-01-05 Impact factor: 13.029
Authors: Mario Mischkulnig; Barbara Kiesel; Martin Borkovec; Lisa I Wadiura; Dimitri Benner; Arthur Hosmann; Shawn Hervey-Jumper; Engelbert Knosp; Karl Roessler; Mitchel S Berger; Georg Widhalm Journal: Lasers Surg Med Date: 2020-03-08 Impact factor: 4.025